BIO-KEY INTERNATIONAL INC (BKYI)
US09060C5076 - Common Stock
Taking everything into account, BKYI scores 1 out of 10 in our fundamental rating. BKYI was compared to 279 industry peers in the Software industry. BKYI has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, BKYI is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
BKYI had negative earnings in the past year.
In the past year BKYI has reported a negative cash flow from operations.
In the past 5 years BKYI always reported negative net income.
In the past 5 years BKYI always reported negative operating cash flow.
1.2 Ratios
With a Return On Assets value of -187.29%, BKYI is not doing good in the industry: 95.70% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -187.29% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-107.41%
ROA(5y)-189.86%
ROE(3y)-352.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BKYI's Gross Margin of 9.99% is on the low side compared to the rest of the industry. BKYI is outperformed by 87.46% of its industry peers.
BKYI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for BKYI so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 9.99% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.43%
GM growth 5YN/A
2. Health
2.1 Basic Checks
BKYI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BKYI has been reduced compared to 1 year ago.
Compared to 5 years ago, BKYI has less shares outstanding
BKYI has a better debt/assets ratio than last year.
2.2 Solvency
BKYI has an Altman-Z score of -42.71. This is a bad value and indicates that BKYI is not financially healthy and even has some risk of bankruptcy.
BKYI has a Altman-Z score of -42.71. This is amonst the worse of the industry: BKYI underperforms 97.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -42.71 |
ROIC/WACCN/A
WACC13.52%
2.3 Liquidity
A Current Ratio of 0.54 indicates that BKYI may have some problems paying its short term obligations.
BKYI's Current ratio of 0.54 is on the low side compared to the rest of the industry. BKYI is outperformed by 92.47% of its industry peers.
BKYI has a Quick Ratio of 0.54. This is a bad value and indicates that BKYI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BKYI (0.46) is worse than 92.83% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.54 | ||
| Quick Ratio | 0.46 |
3. Growth
3.1 Past
The earnings per share for BKYI have decreased strongly by -1141.27% in the last year.
The Revenue has grown by 37.38% in the past year. This is a very strong growth!
Measured over the past years, BKYI shows a small growth in Revenue. The Revenue has been growing by 2.19% on average per year.
EPS 1Y (TTM)-1141.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)37.38%
Revenue growth 3Y45.69%
Revenue growth 5Y2.19%
Sales Q2Q%18.32%
3.2 Future
The Earnings Per Share is expected to grow by 21.83% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 6.69% on average over the next years.
EPS Next Y88.65%
EPS Next 2Y30.73%
EPS Next 3Y21.83%
EPS Next 5YN/A
Revenue Next Year42.86%
Revenue Next 2Y-1.3%
Revenue Next 3Y6.69%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
BKYI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BKYI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as BKYI's earnings are expected to grow with 21.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.73%
EPS Next 3Y21.83%
5. Dividend
5.1 Amount
BKYI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIO-KEY INTERNATIONAL INC
NASDAQ:BKYI (11/22/2024, 8:26:16 PM)
After market: 0.8977 +0.02 (+2.01%)0.88
+0.04 (+5.25%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.75M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -187.29% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 9.99% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.54 | ||
| Quick Ratio | 0.46 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-1141.27%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y88.65%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)37.38%
Revenue growth 3Y45.69%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y